CrossRef Phellinus igniarius Polysaccharides Ameliorate Nonalcoholic Fatty Liver Disease Through Suppressing SREBP1 YingJun Zhang, KaiYue He, WeiTao Yin, QingChun Zhao, XiongYan Xiang, JunQi Li, ZhiFeng Zhang, YongPing Jian, ZhiXiang Xu Food Frontiers .2026;[Epub] CrossRef Development and validation of an explainable machine learning model using routine laboratory biomarkers for identifying prevalent MASLD: Evidence from two observational studies Jialin Wu, Wenting Wei, Terry Cheuk-Fung Yip, Xinyi Deng, Bonan Chen, Yang Lyu, Peiyao Yu, Tiejun Feng, Fuda Xie, Ge Zhang, Kangmin Zhuang, Aimin Li, Wei Kang Clinical and Experimental Medicine .2026;[Epub] CrossRef Weight loss and alcohol reduction synergize for hepatic steatosis remission in elderly patients with metabolic alcohol-associated liver disease (MetALD): a retrospective cohort study Tianxiang Lin, Xiaoxue Yuan, Yanrong Zhao, Wei Wang, Chen Wu, Song Yang, Yinwei Qiu International Journal of Obesity .2026;[Epub] CrossRef Hepatic and Cardiovascular Outcomes in Primary Biliary Cholangitis With MetabolicDysfunction Associated Steatotic Liver Disease Jarell JieRae Tan, Joo Wei Ethan Quek, Sean Shao Wei Lam, MingHua Zheng, Christophe Corpechot, Aldo J
This allows for comprehensive medication review, assessment of potential interactions with other medications, and appropriate monitoring
Cagrilintide showed similar directional improvements, though the magnitude was generally proportional to the degree of weight loss rather than suggesting independent cardiovascular effects
They are clinical signals that the treatment plan, medication dose, nutrition strategy, exercise prescription, or underlying medical status may need reassessment
and the greatest batch continuity, since one vial means one batch and one purity figure across a long protocol instead of several stitched together
The main challenge being, making these drug delivery devices the prefilled pens themselves
